Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment Podcast Por  arte de portada

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones